Inhibrx Biosciences, Inc. (INBX) support and resistance · rev $1.3M
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
This page maps Inhibrx Biosciences, Inc. (INBX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
INBX currently screens at market cap $1.28B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new INBX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the INBX quote page for the session range and the stock page for the full model.
Not investment advice.